Precision BioSciences to Participate in the Truist Securities 2021 Life Sciences Virtual Series

Rhea-AI Summary

Precision BioSciences Inc. (Nasdaq: DTIL) announced that Dr. Derek Jantz, Chief Scientific Officer and Co-Founder, will participate in a fireside chat at the Truist Securities 2021 Life Sciences Virtual Series.

Event Details:
Date: April 13, 2021
Time: 11:00 AM ET
A live webcast will be available on the company's website under the Investors & Media section, with a replay for approximately 30 days following the event.

Precision BioSciences focuses on developing innovative therapies using its proprietary ARCUS® genome editing platform.

Precision BioSciences Inc. (Nasdaq: DTIL), a clinical stage biotechnology company developing allogeneic CAR T and in vivo gene correction therapies with its ARCUS® genome editing platform, today announced that Derek Jantz, Ph.D., Chief Scientific Officer and Co-Founder will participate in a fireside chat at the Truist Securities 2021 Life Sciences Virtual Series.

Details for the fireside chat are below:

The Truist Securities 2021 Life Sciences Virtual Series
Date: Tuesday, April 13, 2021
Time: 11:00 AM ET

A live webcast of the fireside chat will be accessible on the Company’s website www.precisionbiosciences.com, under the Investors & Media section. An archived replay of the webcasts will be available for approximately 30 days following the presentations.

About Precision BioSciences, Inc.

Precision BioSciences, Inc. is a clinical stage biotechnology company dedicated to improving life (DTIL) with its wholly proprietary ARCUS® genome editing platform. ARCUS is a highly specific and versatile genome editing platform that was designed with therapeutic safety, delivery, and control in mind. Using ARCUS, the Company’s pipeline consists of multiple “off-the-shelf” CAR T immunotherapy clinical candidates and several in vivo gene correction therapy candidates to cure genetic and infectious diseases where no adequate treatments exist. For more information about Precision BioSciences, please visit www.precisionbiosciences.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210409005439/en/

FAQ

What is the date and time of the fireside chat featuring Derek Jantz from Precision BioSciences?

The fireside chat is scheduled for April 13, 2021, at 11:00 AM ET.

How can I watch the Precision BioSciences fireside chat?

You can watch the fireside chat live on the Precision BioSciences website under the Investors & Media section.

What platform does Precision BioSciences use for genome editing?

Precision BioSciences uses its proprietary ARCUS® genome editing platform.

What is the focus of Precision BioSciences' research?

Precision BioSciences focuses on developing allogeneic CAR T and in vivo gene correction therapies.

Will there be a replay of the fireside chat hosted by Precision BioSciences?

Yes, an archived replay will be available for approximately 30 days following the presentation.